Key result
Combined therapy with corticosteroids and plasma exchange resulted in survival for 3 out of 3 patients with cholesterol atheroembolic renal failure, whereas the 2 remaining patients died.
Why the study?
Does combined therapy with corticosteroids and plasma exchange improve survival and renal function in patients with cholesterol atheroembolic renal failure?
Case Report (n=5)
Does combined therapy with corticosteroids and plasma exchange improve survival and renal function in patients with cholesterol atheroembolic renal failure?
Absolute Event Rate: 100% vs 0%
Combined therapy with corticosteroids and plasma exchange may offer survival and renal benefits in patients with cholesterol atheroembolic renal failure.
No takes yet. Share an insight, caveat, or question.
Should not yet change practice in cholesterol atheroembolic renal failure; leaves open possible benefit from combined corticosteroids and plasma exchange.
Hasegawa et al. (2000) conducted a case report in Cholesterol atheroembolic renal failure (n=5). Corticosteroids and plasma exchange vs. No combined therapy was evaluated on Survival and improvement in renal function. Combined therapy with corticosteroids and plasma exchange resulted in survival for 3 out of 3 patients with cholesterol atheroembolic renal failure, whereas the 2 remaining patients died.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: